Papp B, Enyedi A, Pászty K, Kovács T, Sarkadi B, Gárdos G, Magnier C, Wuytack F, Enouf J
U-348 INSERM, Hôpital Lariboisière, Paris, France.
Biochem J. 1992 Nov 15;288 ( Pt 1)(Pt 1):297-302. doi: 10.1042/bj2880297.
Phosphorylation, immunoblotting, limited proteolysis and drug-sensitivity analysis were used to characterize the sarcoendoplasmic-reticulum Ca2+ ATPases in a variety of human cell types. In platelets, several megakaryoblastoid and lymphoblastoid cell lines two distinct autophosphorylated forms of these ATPases with molecular mass of 100 and 97 kDa could be observed, whereas in several other cell types the 97 kDa form was absent. On immunoblots the 97 kDa species was specifically recognized by an inhibitory monoclonal antibody raised against the Ca2+ pump of platelet internal membranes, yielded on trypsinolysis a major fragment of 80 kDa, exhibited a distinct electrophoretic migration pattern as compared with the skeletal-, cardiac- and smooth-muscle Ca2+ pumps, and its autophosphorylation was strongly inhibited by the Ca(2+)-mobilizing agent 2,5-di-(t-butyl)-1,4-benzohydroquinone (tBHQ). The 100 kDa species reacted with an antibody specific for the cardiac- and smooth-muscle Ca2+ pumps, yielded on trypsinolysis fragments of 55 and 35 kDa, and its autophosphorylation was much less sensitive to tBHQ inhibition. These findings indicate the simultaneous presence of two different endoplasmic-reticulum Ca2+ pumps in a variety of human cell types, and may explain the previously observed differences in the Ca(2+)-handling characteristics of different intracellular Ca2+ pools and cell types.
磷酸化、免疫印迹、有限蛋白酶解及药物敏感性分析被用于表征多种人类细胞类型中的肌浆网Ca2+ATP酶。在血小板、几种巨核母细胞样和淋巴母细胞样细胞系中,可观察到这些ATP酶有两种不同的自磷酸化形式,分子量分别为100 kDa和97 kDa,而在其他几种细胞类型中则不存在97 kDa的形式。在免疫印迹上,97 kDa的蛋白被一种针对血小板内膜Ca2+泵产生的抑制性单克隆抗体特异性识别,经胰蛋白酶消化后产生一个主要的80 kDa片段,与骨骼肌、心肌和平滑肌的Ca2+泵相比,呈现出独特的电泳迁移模式,其自磷酸化受到Ca(2+)动员剂2,5-二-(叔丁基)-1,4-苯二酚(tBHQ)的强烈抑制。100 kDa的蛋白与一种针对心肌和平滑肌Ca2+泵的特异性抗体发生反应,经胰蛋白酶消化后产生55 kDa和35 kDa的片段,其自磷酸化对tBHQ抑制的敏感性要低得多。这些发现表明,在多种人类细胞类型中同时存在两种不同的内质网Ca2+泵,这可能解释了先前观察到的不同细胞内Ca2+池和细胞类型在Ca(2+)处理特性上的差异。